Sotera Health Appoints Alton Shader as New CEO, Details Substantial Executive Compensation Packages
summarizeSummary
Sotera Health appoints Alton Shader as CEO, with Michael B. Petras, Jr. becoming Executive Chairman, detailing comprehensive compensation packages for both roles.
check_boxKey Events
-
New CEO Appointed
Alton Shader, previously CEO of Viant Medical, has been appointed Chief Executive Officer and a Class II director, effective May 26, 2026. He brings over 20 years of medical industry experience.
-
Executive Chairman Transition
Michael B. Petras, Jr. will transition from CEO and Chairman to Executive Chairman of the Board, remaining actively involved in investor relations, commercial, and litigation strategy.
-
New CEO Compensation Detailed
Mr. Shader's compensation includes a $1,000,000 annual base salary, 110% target bonus, a $6,000,000 sign-on RSU grant, and initial annual equity awards totaling $8,125,000 for 2026, with future annual long-term incentive awards targeted at $6,500,000.
-
Executive Chairman Compensation Detailed
Mr. Petras, as Executive Chairman, will receive an annual base salary of $900,000, a 110% target bonus, and will be eligible for annual long-term incentive awards with a target grant date fair value of $5,000,000 starting in 2027.
auto_awesomeAnalysis
Sotera Health has announced a significant leadership transition, appointing Alton Shader, formerly CEO of Viant Medical, as its new Chief Executive Officer. This move is part of a planned succession, with former CEO Michael B. Petras, Jr. transitioning to Executive Chairman. The filing provides extensive details on the compensation packages for both executives, including a substantial $6 million sign-on equity award for Mr. Shader and significant annual long-term incentive awards for both. This detailed disclosure is crucial for investors to understand the company's executive incentives and the financial implications of the leadership change, which appears to be a smooth, strategically planned transition aimed at leveraging new leadership while retaining experienced guidance.
At the time of this filing, SHC was trading at $15.33 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $4.4B. The 52-week trading range was $10.80 to $19.85. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.